Govindan, R., Fakih, M. G., Price, T. J., Falchook, G. S., Desai, J., Kuo, J. C., … Hong, D. S. (2019). P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer. In Journal of Thoracic Oncology (Vol. 14, pp. S1191–S1192). Elsevier BV. https://doi.org/10.1016/j.jtho.2019.09.181

Govindan, R., M. G. Fakih, T. J. Price, G. S. Falchook, J. Desai, J. C. Kuo, J. H. Strickler, et al. “P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer.” In Journal of Thoracic Oncology, 14:S1191–92. Elsevier BV, 2019. https://doi.org/10.1016/j.jtho.2019.09.181.

Govindan R, Fakih MG, Price TJ, Falchook GS, Desai J, Kuo JC, et al. P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer. In: Journal of Thoracic Oncology. Elsevier BV; 2019. p. S1191–2.

Govindan, R., et al. “P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer.” Journal of Thoracic Oncology, vol. 14, no. 11, Elsevier BV, 2019, pp. S1191–92. Crossref, doi:10.1016/j.jtho.2019.09.181.

Govindan R, Fakih MG, Price TJ, Falchook GS, Desai J, Kuo JC, Strickler JH, Krauss JC, Li BT, Denlinger CS, Durm G, Ngang J, Henary H, Ngarmchamnanrith G, Rasmussen E, Morrow PK, Hong DS. P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. Elsevier BV; 2019. p. S1191–S1192.